Skip to content
26 October · 06:30 UTCFollow AstraZeneca by emailFollow

AZN · story · 20 October – 25 October

AstraZeneca signs $1.46bn AI deal

AstraZeneca · 4 headlines from 1 outlet, from 20 October 2026 to 25 October 2026.

The story

+6.3strongly positive
Headlines4
Outlets1
Days420 October – 25 October

A report links a $40m AI deal with a Citi target of 18,600p.

Tone by day

Average of each day's headlines, −10 to +10.

Source: MarketFrame news analysis

Tone by day. Average of each day's headlines, −10 to +10. Source: MarketFrame news analysis
dayAverage tone
20 Oct6.7
22 Oct5.8
24 Oct9.2
25 Oct3.3

The story's tone is the average of its headlines' own scores. Each score rates how good or bad the news was for the company, from −10 (clearly bad) to +10 (clearly good). 0 is neutral, and anything beyond ±6 is strong and rare. It rates the coverage, not the share price.

How each outlet covered it · 1 outlet

OutletHeadlinesAverage tone
AD HOC NEWS4+6.3

One or two headlines is not a lean: read these as how this story was told, not as a verdict on the outlet.

Day by day · 4 days, strongest headlines first

Sunday 25 October 20261 headline · AstraZeneca has revealed a deal involving AI, and its shares are priced at EUR 153.53.+3.3
ToneWhat the article reported, and why it scored that waySource
+3.3AI deal announced; little detail, mildly positive.AD HOC NEWS (opens the article) ↗
Saturday 24 October 20261 headline · AstraZeneca agreed an AI deal worth USD 1.46 billion.+9.2
ToneWhat the article reported, and why it scored that waySource
+9.2Signs $1.46bn AI deal ahead of results.AD HOC NEWS (opens the article) ↗
Thursday 22 October 20261 headline · AstraZeneca agreed an AI deal worth USD 40 million.+5.8
ToneWhat the article reported, and why it scored that waySource
+5.8Agrees an AI deal valued at USD 40 million.AD HOC NEWS (opens the article) ↗
Tuesday 20 October 20261 headline · A report links a $40m AI deal with a Citi target of 18,600p.+6.7
ToneWhat the article reported, and why it scored that waySource
+6.7AI deal and high Citi price target.AD HOC NEWS (opens the article) ↗

Follow by email

A short, free morning email on how the news treated AstraZeneca: the tone, the stories behind it, and when coverage starts to turn. Launching soon; one click to unsubscribe.

How it works. Every morning an AI model reads the UK business news about each FTSE 100 company and scores how good or bad it is for the company, from −10 to +10. Pages update by about 07:45 UK time.

Not investment advice. MarketFrame rates the tone of news coverage. It is general information, not a recommendation to buy or sell anything. The scores are not share-price data or forecasts: a good score doesn't mean a share will rise, and a bad one doesn't mean it will fall.

Data to 06:30 UTC, 26 October · 326 headlines · 63 companiesMade by Adapt Progress Evolve Limited, a UK company · Privacy · Terms · RSS · API · llms.txt